2.83  0.04 (1.43%)		06-25 16:00
Open: 2.79 High: 2.87 Volume: 69,435		Pre. Close: 2.79 Low: 2.76 Market Cap: 188(M)

Short term
Mid term
Targets	6-month :	3.88	1-year :	4.46
Resists	First :	3.32	Second :	3.81
Pivot price	3.01
Supports	First :	2.51	Second :	2.09
MAs	MA(5) :	2.74	MA(20) :	3.03
	MA(100) :	3	MA(250) :	3.05
MACD	MACD :	-0.2	Signal :	-0.1
%K %D	K(14,3) :	27.5	D(3) :	21
RSI	RSI(14): 44.4
52-week	High :	6.98	Low :	0.86

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ GBIO ] has closed above bottom band by 32.1%. Bollinger Bands are 2.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	2.87 - 2.89	2.89 - 2.9
Low:	2.73 - 2.74	2.74 - 2.76
Close:	2.81 - 2.83	2.83 - 2.85

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Sun, 23 Jun 2024
KBR, Inc. (NYSE:KBR) Shares Sold by PNC Financial Services Group Inc. - Defense World

Sun, 23 Jun 2024
Nomura Holdings Inc. Acquires Shares of 2006 Celanese Co. (NYSE:CE) - Defense World

Fri, 14 Jun 2024
Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit - Marketscreener.com

Mon, 27 May 2024
In the Green: Generation Bio Co (GBIO) Closes at 3.07, Up/Down -1.92 from Previous Day – DWinneX - The Dwinnex

Thu, 22 Feb 2024
Generation Bio: Too Late To Pivot? (NASDAQ:GBIO) - Seeking Alpha

Tue, 06 Feb 2024
Generation Bio ends Waltham lease, but landlord fights back - The Business Journals

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	67 (M)
Shares Float	49 (M)
Held by Insiders	14.5 (%)
Held by Institutions	83.2 (%)
Shares Short	1,620 (K)
Shares Short P.Month	1,580 (K)

EPS	-2.55
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	1.99
Profit Margin	0 %
Operating Margin	-510.1 %
Return on Assets (ttm)	-21.7 %
Return on Equity (ttm)	-82.3 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0.14
EBITDA (p.s.)	-1.8
Qtrly Earnings Growth	0 %
Operating Cash Flow	-57 (M)
Levered Free Cash Flow	-5 (M)

PE Ratio	-1.11
PEG Ratio	0
Price to Book value	1.42
Price to Sales	18.9
Price to Cash Flow	-3.32

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.